EMEA (Europe, Middle East and Africa) Alpha Galactosidase A Market Report 2017

December 2017 | 101 pages | ID: E8669EE1D5DEN
QYResearch

Abstracts

In this report, the EMEA Alpha Galactosidase A market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Alpha Galactosidase A for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Alpha Galactosidase A market competition by top manufacturers/players, with Alpha Galactosidase A sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amicus Therapeutics, Inc.
• Greenovation Biotech GmbH
• iBio, Inc.
• ISU ABXIS Co.,Ltd.
• JCR Pharmaceuticals Co., Ltd.
• Pharming Group N.V.
• Protalix BioTherapeutics, Inc.
• Shire Plc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Agalsidase Alfa
• AVRRD-01
• Migalastat Hydrochloride
• MOSS-AGAL
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Alpha Galactosidase A Market Report 2017

1 ALPHA GALACTOSIDASE A OVERVIEW

1.1 Product Overview and Scope of Alpha Galactosidase A
1.2 Classification of Alpha Galactosidase A
  1.2.1 EMEA Alpha Galactosidase A Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Alpha Galactosidase A Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Agalsidase Alfa
  1.2.4 AVRRD-01
  1.2.5 Migalastat Hydrochloride
  1.2.6 MOSS-AGAL
  1.2.7 Others
1.3 EMEA Alpha Galactosidase A Market by Application/End Users
  1.3.1 EMEA Alpha Galactosidase A Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Care
1.4 EMEA Alpha Galactosidase A Market by Region
  1.4.1 EMEA Alpha Galactosidase A Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Alpha Galactosidase A (2012-2022)
  1.5.1 EMEA Alpha Galactosidase A Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Alpha Galactosidase A Revenue and Growth Rate (2012-2022)

2 EMEA ALPHA GALACTOSIDASE A COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Alpha Galactosidase A Market Competition by Players/Manufacturers
  2.1.1 EMEA Alpha Galactosidase A Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Alpha Galactosidase A Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Alpha Galactosidase A Sale Price by Players (2012-2017)
2.2 EMEA Alpha Galactosidase A (Volume and Value) by Type/Product Category
  2.2.1 EMEA Alpha Galactosidase A Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Alpha Galactosidase A Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Alpha Galactosidase A Sale Price by Type (2012-2017)
2.3 EMEA Alpha Galactosidase A (Volume) by Application
2.4 EMEA Alpha Galactosidase A (Volume and Value) by Region
  2.4.1 EMEA Alpha Galactosidase A Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Alpha Galactosidase A Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Alpha Galactosidase A Sales Price by Region (2012-2017)

3 EUROPE ALPHA GALACTOSIDASE A (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Alpha Galactosidase A Sales and Value (2012-2017)
  3.1.1 Europe Alpha Galactosidase A Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Alpha Galactosidase A Revenue and Growth Rate (2012-2017)
3.2 Europe Alpha Galactosidase A Sales and Market Share by Type
3.3 Europe Alpha Galactosidase A Sales and Market Share by Application
3.4 Europe Alpha Galactosidase A Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Alpha Galactosidase A Sales Volume by Countries (2012-2017)
  3.4.2 Europe Alpha Galactosidase A Revenue by Countries (2012-2017)
  3.4.3 Germany Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  3.4.4 France Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  3.4.5 UK Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  3.4.6 Russia Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  3.4.7 Italy Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Alpha Galactosidase A Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ALPHA GALACTOSIDASE A (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Alpha Galactosidase A Sales and Value (2012-2017)
  4.1.1 Middle East Alpha Galactosidase A Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Alpha Galactosidase A Revenue and Growth Rate (2012-2017)
4.2 Middle East Alpha Galactosidase A Sales and Market Share by Type
4.3 Middle East Alpha Galactosidase A Sales and Market Share by Application
4.4 Middle East Alpha Galactosidase A Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Alpha Galactosidase A Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Alpha Galactosidase A Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  4.4.4 Israel Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  4.4.5 UAE Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  4.4.6 Iran Alpha Galactosidase A Sales and Growth Rate (2012-2017)

5 AFRICA ALPHA GALACTOSIDASE A (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Alpha Galactosidase A Sales and Value (2012-2017)
  5.1.1 Africa Alpha Galactosidase A Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Alpha Galactosidase A Revenue and Growth Rate (2012-2017)
5.2 Africa Alpha Galactosidase A Sales and Market Share by Type
5.3 Africa Alpha Galactosidase A Sales and Market Share by Application
5.4 Africa Alpha Galactosidase A Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Alpha Galactosidase A Sales Volume by Countries (2012-2017)
  5.4.2 Africa Alpha Galactosidase A Revenue by Countries (2012-2017)
  5.4.3 South Africa Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Alpha Galactosidase A Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Alpha Galactosidase A Sales and Growth Rate (2012-2017)

6 EMEA ALPHA GALACTOSIDASE A MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Amicus Therapeutics, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alpha Galactosidase A Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amicus Therapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Greenovation Biotech GmbH
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Alpha Galactosidase A Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Greenovation Biotech GmbH Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 iBio, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Alpha Galactosidase A Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 iBio, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 ISU ABXIS Co.,Ltd.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Alpha Galactosidase A Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 JCR Pharmaceuticals Co., Ltd.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Alpha Galactosidase A Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pharming Group N.V.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Alpha Galactosidase A Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pharming Group N.V. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Protalix BioTherapeutics, Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Alpha Galactosidase A Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shire Plc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Alpha Galactosidase A Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shire Plc Alpha Galactosidase A Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ALPHA GALACTOSIDASE A MANUFACTURING COST ANALYSIS

7.1 Alpha Galactosidase A Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alpha Galactosidase A

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alpha Galactosidase A Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alpha Galactosidase A Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ALPHA GALACTOSIDASE A MARKET FORECAST (2017-2022)

11.1 EMEA Alpha Galactosidase A Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Alpha Galactosidase A Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Alpha Galactosidase A Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Alpha Galactosidase A Price and Trend Forecast (2017-2022)
11.2 EMEA Alpha Galactosidase A Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Alpha Galactosidase A Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Alpha Galactosidase A Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Alpha Galactosidase A Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Alpha Galactosidase A Sales Forecast by Type (2017-2022)
11.7 EMEA Alpha Galactosidase A Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Alpha Galactosidase A
Figure EMEA Alpha Galactosidase A Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Alpha Galactosidase A Sales Volume Market Share by Type (Product Category) in 2016
Figure Agalsidase Alfa Product Picture
Figure AVRRD-01 Product Picture
Figure Migalastat Hydrochloride Product Picture
Figure MOSS-AGAL Product Picture
Figure Others Product Picture
Figure EMEA Alpha Galactosidase A Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Alpha Galactosidase A by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure EMEA Alpha Galactosidase A Market Size (Million USD) by Region (2012-2022)
Figure Europe Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Alpha Galactosidase A Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Alpha Galactosidase A Revenue (Million USD) Status and Forecast by Countries
Figure Africa Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Alpha Galactosidase A Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Alpha Galactosidase A Sales Volume and Growth Rate (2012-2022)
Figure EMEA Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Alpha Galactosidase A Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Alpha Galactosidase A Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Alpha Galactosidase A Sales Share by Players (2012-2017)
Figure 2016 Alpha Galactosidase A Sales Share by Players
Figure 2017 Alpha Galactosidase A Sales Share by Players
Figure EMEA Alpha Galactosidase A Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Alpha Galactosidase A Revenue (Million USD) by Players (2012-2017)
Table EMEA Alpha Galactosidase A Revenue Share by Players (2012-2017)
Table 2016 EMEA Alpha Galactosidase A Revenue Share by Players
Table 2017 EMEA Alpha Galactosidase A Revenue Share by Players
Table EMEA Alpha Galactosidase A Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Alpha Galactosidase A Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Alpha Galactosidase A Sales Share by Type (2012-2017)
Figure Sales Market Share of Alpha Galactosidase A by Type (2012-2017)
Figure EMEA Alpha Galactosidase A Sales Market Share by Type (2012-2017)
Table EMEA Alpha Galactosidase A Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Alpha Galactosidase A Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alpha Galactosidase A by Type in 2016
Table EMEA Alpha Galactosidase A Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Alpha Galactosidase A Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Alpha Galactosidase A Sales Share by Application (2012-2017)
Figure Sales Market Share of Alpha Galactosidase A by Application (2012-2017)
Figure EMEA Alpha Galactosidase A Sales Market Share by Application in 2016
Table EMEA Alpha Galactosidase A Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Alpha Galactosidase A Sales Share by Region (2012-2017)
Figure Sales Market Share of Alpha Galactosidase A by Region (2012-2017)
Figure EMEA Alpha Galactosidase A Sales Market Share in 2016
Table EMEA Alpha Galactosidase A Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Alpha Galactosidase A Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Alpha Galactosidase A by Region (2012-2017)
Figure EMEA Alpha Galactosidase A Revenue Market Share Regions in 2016
Table EMEA Alpha Galactosidase A Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Alpha Galactosidase A Revenue and Growth Rate (2012-2017)
Table Europe Alpha Galactosidase A Sales (K Pcs) by Type (2012-2017)
Table Europe Alpha Galactosidase A Market Share by Type (2012-2017)
Figure Europe Alpha Galactosidase A Market Share by Type in 2016
Table Europe Alpha Galactosidase A Sales (K Pcs) by Application (2012-2017)
Table Europe Alpha Galactosidase A Market Share by Application (2012-2017)
Figure Europe Alpha Galactosidase A Market Share by Application in 2016
Table Europe Alpha Galactosidase A Sales (K Pcs) by Countries (2012-2017)
Table Europe Alpha Galactosidase A Sales Market Share by Countries (2012-2017)
Figure Europe Alpha Galactosidase A Sales Market Share by Countries (2012-2017)
Figure Europe Alpha Galactosidase A Sales Market Share by Countries in 2016
Table Europe Alpha Galactosidase A Revenue (Million USD) by Countries (2012-2017)
Table Europe Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Europe Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Europe Alpha Galactosidase A Revenue Market Share by Countries in 2016
Figure Germany Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Alpha Galactosidase A Sales (K Pcs) by Type (2012-2017)
Table Middle East Alpha Galactosidase A Market Share by Type (2012-2017)
Figure Middle East Alpha Galactosidase A Market Share by Type (2012-2017)
Table Middle East Alpha Galactosidase A Sales (K Pcs) by Applications (2012-2017)
Table Middle East Alpha Galactosidase A Market Share by Applications (2012-2017)
Figure Middle East Alpha Galactosidase A Sales Market Share by Application in 2016
Table Middle East Alpha Galactosidase A Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Alpha Galactosidase A Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Alpha Galactosidase A Sales Volume Market Share by Countries in 2016
Table Middle East Alpha Galactosidase A Revenue (Million USD) by Countries (2012-2017)
Table Middle East Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Middle East Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Middle East Alpha Galactosidase A Revenue Market Share by Countries in 2016
Figure Saudi Arabia Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Alpha Galactosidase A Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Alpha Galactosidase A Sales (K Pcs) by Type (2012-2017)
Table Africa Alpha Galactosidase A Sales Market Share by Type (2012-2017)
Figure Africa Alpha Galactosidase A Sales Market Share by Type (2012-2017)
Figure Africa Alpha Galactosidase A Sales Market Share by Type in 2016
Table Africa Alpha Galactosidase A Sales (K Pcs) by Application (2012-2017)
Table Africa Alpha Galactosidase A Sales Market Share by Application (2012-2017)
Figure Africa Alpha Galactosidase A Sales Market Share by Application (2012-2017)
Table Africa Alpha Galactosidase A Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Alpha Galactosidase A Sales Market Share by Countries (2012-2017)
Figure Africa Alpha Galactosidase A Sales Market Share by Countries (2012-2017)
Figure Africa Alpha Galactosidase A Sales Market Share by Countries in 2016
Table Africa Alpha Galactosidase A Revenue (Million USD) by Countries (2012-2017)
Table Africa Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Africa Alpha Galactosidase A Revenue Market Share by Countries (2012-2017)
Figure Africa Alpha Galactosidase A Revenue Market Share by Countries in 2016
Figure South Africa Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Table Amicus Therapeutics, Inc. Alpha Galactosidase A Basic Information List
Table Amicus Therapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure Amicus Therapeutics, Inc. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table Greenovation Biotech GmbH Alpha Galactosidase A Basic Information List
Table Greenovation Biotech GmbH Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure Greenovation Biotech GmbH Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table iBio, Inc. Alpha Galactosidase A Basic Information List
Table iBio, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure iBio, Inc. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table ISU ABXIS Co.,Ltd. Alpha Galactosidase A Basic Information List
Table ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure ISU ABXIS Co.,Ltd. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Basic Information List
Table JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table Pharming Group N.V. Alpha Galactosidase A Basic Information List
Table Pharming Group N.V. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure Pharming Group N.V. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table Protalix BioTherapeutics, Inc. Alpha Galactosidase A Basic Information List
Table Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure Protalix BioTherapeutics, Inc. Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table Shire Plc Alpha Galactosidase A Basic Information List
Table Shire Plc Alpha Galactosidase A Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Plc Alpha Galactosidase A Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shire Plc Alpha Galactosidase A Sales Market Share in EMEA (2012-2017)
Figure Shire Plc Alpha Galactosidase A Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alpha Galactosidase A
Figure Manufacturing Process Analysis of Alpha Galactosidase A
Figure Alpha Galactosidase A Industrial Chain Analysis
Table Raw Materials Sources of Alpha Galactosidase A Major Manufacturers in 2016
Table Major Buyers of Alpha Galactosidase A
Table Distributors/Traders List
Figure EMEA Alpha Galactosidase A Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Alpha Galactosidase A Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Alpha Galactosidase A Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Alpha Galactosidase A Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Alpha Galactosidase A Sales Market Share Forecast by Region (2017-2022)
Table EMEA Alpha Galactosidase A Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Alpha Galactosidase A Revenue Market Share Forecast by Region (2017-2022)
Table Europe Alpha Galactosidase A Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Alpha Galactosidase A Sales Market Share Forecast by Countries (2017-2022)
Table Europe Alpha Galactosidase A Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Alpha Galactosidase A Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Alpha Galactosidase A Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Alpha Galactosidase A Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Alpha Galactosidase A Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Alpha Galactosidase A Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Alpha Galactosidase A Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Alpha Galactosidase A Sales Market Share Forecast by Countries (2017-2022)
Table Africa Alpha Galactosidase A Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Alpha Galactosidase A Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Alpha Galactosidase A Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Alpha Galactosidase A Sales Market Share Forecast by Type (2017-2022)
Table EMEA Alpha Galactosidase A Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Alpha Galactosidase A Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources